8 November 2023
ANANDA DEVELOPMENTS PLC
("Ananda" or the "Company")
Investor Presentation via Investor Meet Company
Ananda Developments Plc ('Ananda') is pleased to announce that Melissa Sturgess, Chief Executive Officer, will provide a live presentation update on Ananda via Investor Meet Company on Tuesday 14th November at 9:00am GMT. The presentation follows the Company's recent announcements and Investival Showcase presentation in London on Monday 13th November.
The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation.
Investors can sign up to Investor Meet Company for free and add to meet ANANDA DEVELOPMENTS PLC via:
https://www.investormeetcompany.com/ananda-developments-plc/register-investor
Investors who already follow ANANDA DEVELOPMENTS PLC on the Investor Meet Company platform will automatically be invited.
The video will also be available for viewing after the event on the Company's website and YouTube channel (https://www.youtube.com/@anandadevelopmentsplc7440).
To stay abreast of the latest developments at Ananda, we encourage you to follow our social media channels which are:
· Instagram: https://instagram.com/anandadevelopments?igshid=YmMyMTA2M2Y=
· LinkedIn: https://www.linkedin.com/company/anadevelopments/
· Twitter: https://twitter.com/anandaplc?s=21&t=9yeIC_xYCfzgDn7j26sfuA
-Ends-
The Directors of the Company accept responsibility for the contents of this announcement.
ANANDA DEVELOPMENTS PLC |
+44 (0)7463 686 497 |
|
ir@anandadevelopments.com |
Chief Executive Officer |
|
Melissa Sturgess |
|
|
|
Executive Director |
|
Jeremy Sturgess-Smith |
|
|
|
SP ANGEL CORPORATE FINANCE LLP |
+44 (0)20 3470 0470 |
|
|
Corporate Finance |
|
Richard Morrison |
|
Harry Davies-Ball |
|
|
|
Corporate Broking |
|
Abigail Wayne |
|
Rob Rees |
|
About Ananda Developments
Ananda is an AQSE-listed company whose ambition is to be a leading provider of cannabinoid-based medicines for the treatment of complex, chronic inflammatory pain conditions.
For more information, please visit: https://anandadevelopments.com/